GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CCNE · Dec 31, 2024

CNB FINANCIAL CORP/PA. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000736772-25-000071Bank
Sequential deposit growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

2.96% · CORE · VALID

Net-income growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-5.94% · CORE · VALID

Interest-income growth40thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

10.82% · CORE · VALID

Cash and equivalents65thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$443.0M · CORE · VALID

Sequential loan growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.36% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
2.08%
Current
2.96%
Delta
0.88%
Earnings Growth Decreased
Previous
1.65%
Current
-5.94%
Delta
-7.59%
Interest Income Growth Increased
Previous
10.22%
Current
10.82%
Delta
0.60%
Liquidity Increased
Previous
$360.9M
Current
$443.0M
Delta
$82.1M
Loan Growth Decreased
Previous
2.51%
Current
0.36%
Delta
-2.15%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.